Sign In

William Coyle

Principal at ZS Associates

Bill Coyle is the Region Managing Principal for East Asia at ZS Associates, a position he has held since September 2021.1 He is also the Chairman of ZS Associates and serves as the global head of biopharma.2 With nearly 20 years of experience at ZS, Coyle has worked in both the U.S. and Switzerland, developing expertise in various aspects of the pharmaceutical and biotech sector.2

Career Highlights

  • Current Roles:

    • Region Managing Principal for East Asia, leading ZS's operations in China, Japan, and Singapore2
    • Chairperson of ZS's shareholders' council2
    • Global head of biopharma2
  • Previous Positions:

    • Principal at ZS Associates (March 2004 - August 2021)1
    • Managing Principal for Europe (January 2017 - December 2020)1

Expertise

Coyle's expertise spans asset development, early commercialization, value and access, and key account strategy development.2 He has supported more than 20 pharma and biotech product launches worldwide.2

Education

  • MBA from Northwestern University's Kellogg School of Management12
  • BS in Chemical Engineering from the University of Maryland, graduating cum laude12

Additional Information

Before joining ZS in 2004, Coyle worked as a key account manager and marketing sector leader for BASF in the engineered plastics industry.2 His LinkedIn profile indicates he is based in Zurich, Switzerland.1

Highlights

Jul 25 · linkedin

Celebration would be premature, but news of a first-in-human trial for an in vivo CAR-T therapy is reason for excitement. Thousands are alive today thanks to today’s generation of CAR-Ts, but the high cost of these therapies puts them out of reach for many—especially (but not exclusively) in low- and middle-income countries.

This may change in the not-too-distant future, with Interius Biotherapuetics announcing a phase 1 trial of a first-of-its-kind cell therapy for cancer administered through IV infusion. If successful, this approach would preclude the need for the costly, complex and time-consuming manufacturing process that characterizes today’s CAR-Ts, potentially dropping the price tag from hundreds of thousands of dollars to under $10,000.

Early days but hugely promising.   #cellandgene #CGT #oncology

Related Questions

What are Bill Coyle's key achievements at ZS Associates?
How has Bill Coyle's background in chemical engineering influenced his career?
What strategies does Bill Coyle recommend for pharmaceutical companies?
How has Bill Coyle's role evolved since he became the Region Managing Principal in East Asia?
What are some notable projects Bill Coyle has led at ZS Associates?
William Coyle
Add to my network

Location

Zurich, Switzerland